Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$34,549 Mln
P/E Ratio
27.79
P/B Ratio
5.73
Industry P/E
92.42
Debt to Equity
0.56
ROE
0.21 %
ROCE
14.39 %
Div. Yield
0.82 %
Book Value
--
EPS
--
CFO
$10,484.00 Mln
EBITDA
$12,959.00 Mln
Net Profit
$7,849.00 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Agilent Technologies (A)
| -8.87 | -9.10 | -10.29 | -16.99 | -3.64 | 11.69 | 11.40 |
|
BSE Sensex
| -3.77 | -0.92 | -6.67 | 3.66 | 9.18 | 19.75 | 10.11 |
|
S&P Midcap 400
| -5.36 | -7.78 | -8.87 | 0.89 | 3.19 | 16.02 | 6.92 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Agilent Technologies (A)
| -3.35 | -7.10 | -6.26 | 35.50 | 39.79 | 27.54 | 1.66 |
|
S&P Midcap 400
| 12.12 | 14.45 | -14.48 | 23.21 | 11.81 | 24.05 | -12.43 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 79.71 | 16,240.51 | 39.24 | 5.18 | |
| 92.40 | 119,366.00 | 28.38 | 8.69 | |
| 31.18 | 2,755.07 | 20.35 | 14.33 | |
| 236.36 | 36,983.33 | 52.73 | 12.96 |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and... Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Address: 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 Read more
CEO, President & Director
Mr. Michael R. McMullen
CEO, President & Director
Mr. Padraig McDonnell
Headquarters
Santa Clara, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Agilent Technologies Inc (A) stood at $ 13,783 Mln as on 31-Jan-25
The share price of Agilent Technologies Inc (A) is $122.42 (NYSE) as of 18-Mar-2025 14:43 EDT. Agilent Technologies Inc (A) has given a return of -3.64% in the last 3 years.
Agilent Technologies Inc (A) has a market capitalisation of $ 34,549 Mln as on 17-Mar-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Agilent Technologies Inc (A) is 5.73 times as on 17-Mar-2025, a 54% premium to its peers’ median range of 3.72 times.
The P/E ratio of Agilent Technologies Inc (A) is 27.79 times as on 17-Mar-2025, a 70% discount to its peers’ median range of 92.42 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Agilent Technologies Inc (A) and enter the required number of quantities and click on buy to purchase the shares of Agilent Technologies Inc (A).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Address: 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051
The CEO & director of Mr. Michael R. McMullen. is Agilent Technologies Inc (A), and CFO & Sr. VP is Mr. Padraig McDonnell.
There is no promoter pledging in Agilent Technologies Inc (A).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
3,571
|
|
|
1,813
|
|
|
12,064
|
|
|
276
|
| Agilent Technologies Inc. (A) | Ratios |
|---|---|
|
Return on equity(%)
|
21.11
|
|
Operating margin(%)
|
17.34
|
|
Net Margin(%)
|
19.27
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Agilent Technologies Inc (A) was $0 Mln.
$-0.07
(
